2796 — Pharmarise Holdings Balance Sheet
0.000.00%
Last trade - 00:00
- ¥7bn
- ¥13bn
- ¥52bn
- 65
- 89
- 26
- 68
2019 May 31st | 2020 May 31st | 2021 May 31st | 2022 May 31st | 2023 May 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | Yuho | Yuho | Yuho | Yuho | Yuho |
Standards: | JAS | JAS | JAS | JAS | JAS |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Cash and Short Term Investments | 4,403 | 4,472 | 4,604 | 3,991 | 4,742 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 2,850 | 3,323 | 3,085 | 4,265 | 4,017 |
Total Inventory | |||||
Total Other Current Assets | |||||
Total Current Assets | 9,601 | 10,676 | 10,546 | 10,878 | 11,372 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 6,290 | 6,332 | 6,434 | 6,355 | 6,010 |
Net Goodwill | |||||
Net Intangible Assets | |||||
Long Term Investments | |||||
Long Term Notes Receivable | |||||
Other Long Term Assets | |||||
Total Assets | 24,217 | 25,206 | 24,724 | 23,746 | 23,421 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 9,347 | 10,036 | 9,392 | 8,477 | 9,835 |
Long Term Debt | |||||
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Deferred Income Tax | |||||
Minority Interest | |||||
Total Other Liabilities | |||||
Total Funded Status | |||||
Total Liabilities | 18,751 | 19,297 | 18,503 | 17,138 | 16,539 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Treasury Stock | |||||
Unrealized Gain / Loss | |||||
Other Equity | |||||
Total Equity | 5,466 | 5,909 | 6,221 | 6,608 | 6,882 |
Total Liabilities & Shareholders' Equity | 24,217 | 25,206 | 24,724 | 23,746 | 23,421 |
Total Common Shares Outstanding |